Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
BACKGROUND: Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. Subsequent trials in asymptomatic or early symptomatic HIV infection indicated short-term delays in disease progression with AZT, but not improved survival. OBJECTIVES: To assess the effects of immediate...
Hlavní autoři: | Darbyshire, J, Foulkes, M, Peto, R, Duncan, W, Babiker, A, Collins, R, Hughes, M, Peto, T, Walker, A |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2000
|
Podobné jednotky
-
Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
Autor: Darbyshire, J, a další
Vydáno: (2000) -
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Autor: Darbyshire, J, a další
Vydáno: (2000) -
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
Autor: Darbyshire, J, a další
Vydáno: (2000) -
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
Autor: Darbyshire, J, a další
Vydáno: (2000) -
Immediate versus deferred zidovudine.
Autor: Peto, R, a další
Vydáno: (1993)